Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of non-toxigenic vaccine strains of Bordetella pertussis by gene replacement.

Advances in experimental medicine and biology - 1 Jan 1991

Cockle S, Zealey G, Loosmore S, Yacoob R, Fahim R, Yang Y P, Jackson G, Boux H, Boux L, Klein M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Bacterial
Share to Bordetella pertussis
Share to Guinea Pigs
Share to Mice

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Pertussis Vaccine

Share to Vaccines, Synthetic

Share to Virulence Factors, Bordetella

Source

Identifiers

PMID: 1805567
DOI: 10.1007/978-1-4684-6000-1_24

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of non-toxigenic vaccine strains of Bordetella pertussis by gene replacement.PMID 1805567Read ↗

Gene replacement in Bordetella pertussis by transformation with linear DNA.Semantic proximity Read ↗

Genetic approaches to a vaccine for pertussis.Semantic proximity Read ↗

Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin.Semantic proximity Read ↗

Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.Semantic proximity Read ↗

Pertussis vaccines, epidemiology and evolutionSemantic proximity Read ↗

Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune response.Semantic proximity Read ↗

The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.Semantic proximity Read ↗

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.Semantic proximity Read ↗

Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.Semantic proximity Read ↗

Genetic verification of Bordetella pertussis seed strains used for production of Japanese acellular pertussis vaccines.Semantic proximity Read ↗

Genetically derived toxoids for use as vaccines and adjuvants.Semantic proximity Read ↗

Bordetella pertussisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.